Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CONMED Corp Director's Dealing 2014

Jul 31, 2014

31971_dirs_2014-07-31_215bd998-c1ea-4be6-b9d6-9e05300a14d2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2014-07-30

Reporting Person: JONAS DANIEL (EVP Legal Affairs,Gen. Counsel)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-07-30 Common Stock M 2000 $16.46 Acquired 12046 Direct
2014-07-30 Common Stock F 1256 $39.38 Disposed 10790 Direct
2014-07-30 Common Stock M 2000 $19.26 Acquired 12790 Direct
2014-07-30 Common Stock F 1348 $39.38 Disposed 11442 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-07-30 Sars (Stock Appreciation Rights) $16.46 M 2000 Disposed 2019-06-01 Common Stock (2000) Direct
2014-07-30 Sars (Stock Appreciation Rights) $19.26 M 2000 Disposed 2020-06-01 Common Stock (2000) Direct

Footnotes

F1: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.